Inflammatory Response Using Different Lipid Parenteral Nutrition Formulas in Children After Hematopoietic Stem Cell Transplantation

References

• Filicko J, Lazarus HM, and Flomenberg N: Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant 31, 1–10, 2003.
   PubMed Web of Science ®Google Scholar
• Murray SM and Pindoria S: Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 1, CD002920, 2009. doi: 10.1002/14651858.CD002920.pub3
   Web of Science ®Google Scholar
• Muscaritoli M, Grieco G, Capria S, Iori AP, and Rossi Fanelli F: Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 75, 183–190, 2002.
   PubMed Web of Science ®Google Scholar
• Wanten GJ and Calder PC: Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 85, 1171–1184, 2007.
   PubMed Web of Science ®Google Scholar
• Marik PE: Maximizing efficacy from parenteral nutrition in critical care: appropriate patient populations, supplemental parenteral nutrition, glucose control, parenteral glutamine, and alternative fat sources. Curr Gastroenterol Rep 9, 345–353, 2007.
   PubMedGoogle Scholar
• Waitzberg DL and Torrinhas RS: Fish oil lipid emulsions and immune response: what clinicians need to know. Nutr Clin Pract 24, 487–499, 2009.
   PubMed Web of Science ®Google Scholar
• Calder PC: Rationale and use of n-3 fatty acids in artificial nutrition. Proc Nutr Soc 69, 565–573, 2010.
   PubMed Web of Science ®Google Scholar
• Heller AR, Rössler S, Litz RJ, Stehr SN, Heller SC, et al.: Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 34, 972–979, 2006.
   PubMed Web of Science ®Google Scholar
• Wang X, Li W, Li N, and Li J: Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease seque- lae in severe acute pancreatitis: a randomized and controlled study. J Parenter Enteral Nutr 32, 236–241, 2008.
   PubMed Web of Science ®Google Scholar
• Friesecke S, Lotze C, Köhler J, Heinrich A, Felix SB, et al.: Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 34, 1411–1420, 2008.
   PubMed Web of Science ®Google Scholar
• Ott J, Hiesgen C, and Mayer K: Lipids in critical care medicine. Prostaglandins Leukot Essent Fatty Acids 85, 267–273, 2011.
   PubMed Web of Science ®Google Scholar
• Sweeney B, Puri P, and Reen DJ: Modulation of immune cell function by polyunsaturated fatty acids. Pediatr Surg Int 21, 335–340, 2005.
   PubMed Web of Science ®Google Scholar
• Lansky SB, List MA, Lansky LL, Ritter-Sterr C, and Miller DR: The measurement of performance in childhood cancer patients. Cancer 60, 1651–1656, 1987.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, et al.: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5, 649–655, 1982.
   PubMed Web of Science ®Google Scholar
• Kellar KL and Douglass JP: Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. Immunol Methods 279, 277–285, 2003.
   PubMed Web of Science ®Google Scholar
• Hartman C, Ben-Artzi E, Berkowitz D, Elhasid R, Lajterer N, et al.: Olive oil-based intravenous lipid emulsion in pediatric patients undergoing bone marrow transplantation: a short-term prospective controlled trial. Clin Nutr 28, 631–635, 2009.
   PubMed Web of Science ®Google Scholar
• D'Ascenzo R, D'Egidio S, Angelini L, Bellagamba MP, Manna M, et al.: Parenteral nutrition of preterm infants with a lipid emulsion containing 10% fish oil: effect on plasma lipids and long-chain polyunsaturated fatty acids. J Pediatr 159, 33–38, 2011.
   PubMed Web of Science ®Google Scholar
• Rayyan M, Devlieger H, Jochum F, and Allegaert K: Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. J Parenter Enteral Nutr 36, 81S–94S, 2012.
   PubMed Web of Science ®Google Scholar
• Wang J, Yu JC, Kang WM, and Ma ZQ: Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/ long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Nutrition 28, 623–629, 2012.
   PubMed Web of Science ®Google Scholar
• Sungurtekin H, Değirmenci S, Sungurtekin U, Oguz BE, Sabir N, et al.: Comparison of the effects of different intravenous fat emulsions in patients with systemic inflammatory response syndrome and sepsis. Nutr Clin Pract 26, 665–671, 2011.
   PubMed Web of Science ®Google Scholar
• Baena-Gómez MA, de la Torre Aguilar MJ, Mesa MD, Llorente-Cantarero FJ, Pérez Navero JL, et al.: Effects of parenteral nutrition formulas on plasma lipid profile in children with bone marrow transplantation. Ann Nutr Metab 63, 103–110, 2013.
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Conversano L, Torelli GF, Arcese W, Capria S, et al.: Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation 66, 610–616, 1998.
   PubMed Web of Science ®Google Scholar
• Gebremedhin E, Behrendt CE, Nakamura R, Parker P, Salehian B: Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease. Inflammation 36, 177–185, 2013.
   PubMed Web of Science ®Google Scholar
• Sane S, Baba M, Kusano C, Shirao K, Andoh T, et al.: Eicosapentaenoic acid reduces pulmonary edema in endotoxemic rats. J Surg Res 93, 21–7, 2000.
   PubMed Web of Science ®Google Scholar
• Sadeghi S, Wallace FA, and Calder PC: Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 96, 404–410, 1999.
   PubMed Web of Science ®Google Scholar
• Rayon JI, Carver JD, Wyble LE, Wiener D, Dickey SS, et al.: The fatty acid composition of maternal diet affects lung prostaglandin E2 levels and survival from group B streptococcal sepsis in neonatal rat pups. J Nutr 127, 1989–1992, 1997.
   PubMed Web of Science ®Google Scholar
• Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, et al.: Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Bone Marrow Transplant 48, 698–702, 2013.
   PubMed Web of Science ®Google Scholar
• Barbosa VM, Miles EA, Calhau C, Lafuente E, and Calder PC: Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 14, R5, 2010.
   PubMed Web of Science ®Google Scholar
• Hao W, Wong OY, Liu X, Lee P, Chen Y, et al.: ω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J Pediatr Surg 45, 2412–2418, 2010.
   PubMed Web of Science ®Google Scholar
• Ni G, Wang T, Walton S, Zhu B, Chen S, et al.: Manipulating IL-10 signalling blockade for better immunotherapy. Cell Immunol 293, 126–129, 2015.
   PubMed Web of Science ®Google Scholar
• Sharif MN, Tassiulas I, Hu Y, Mecklenbrauker I, Tarakhovsky A, et al.: IFN-alpha priming results in a gain of proinflammatory function by IL-10. Implications for systemic Lupus Erythematosus pathogenesis. J Immunol 172, 6476–6481, 2004.
   PubMed Web of Science ®Google Scholar
• Trifunović J, Miller L, Debeljak Ž, and Horvat V: Pathologic patterns of interleukin 10 expression – A review. Biochem Med 25, 36–48, 2015.
   PubMed Web of Science ®Google Scholar
• López-Alarcón M, Bernabe-García M, del Valle O, González-Moreno G, Martínez-Basilea A, et al.: Oral administration of docosahexaenoic acid attenuates interleukin-1β response and clinical course of septic neonates. Nutrition 28, 384–390, 2012.
   PubMed Web of Science ®Google Scholar
• Fetterman JW Jr and Zdanowicz MM: Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm 66, 1169–1179, 2009.
   PubMed Web of Science ®Google Scholar
• Farias MM and Klaassen J: Nuevas emulsiones lipiìdicas enriquecidas con omega-3: ¿beneficios reales en nutricioìn parenteral?. Rev Chil Nutr 38, 77–83, 2011.
   Google Scholar
• Calder PC: N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38, 343–352, 2003.
   PubMed Web of Science ®Google Scholar
• Siriwardhana N, Kalupahana NS, and Moustaid-Moussa N: Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res 65, 211–222, 2012.
   PubMedGoogle Scholar
• Calder PC: Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 91, 791–795, 2009.
   PubMed Web of Science ®Google Scholar
• Elia M, Van Bokhorst-de van der Schueren MA, Garvey J, Goedhart A, Lundholm K, et al.: Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 28, 5–23, 2006.
   PubMed Web of Science ®Google Scholar
• Takatsuka H, Takemoto Y, Iwata N, Suehiro A, Hamano T, et al.: Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 28, 769–774, 2001.
   PubMed Web of Science ®Google Scholar